Lifeward (LFWD) Competitors $0.56 -0.01 (-2.45%) Closing price 04:00 PM EasternExtended Trading$0.56 +0.01 (+0.99%) As of 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock LFWD vs. NMTC, POCI, TMDIF, VVOS, CLGN, RVP, ICU, NRXS, COCH, and DRIOShould you be buying Lifeward stock or one of its competitors? The main competitors of Lifeward include NeuroOne Medical Technologies (NMTC), Precision Optics (POCI), Titan Medical (TMDIF), Vivos Therapeutics (VVOS), CollPlant Biotechnologies (CLGN), Retractable Technologies (RVP), SeaStar Medical (ICU), NeurAxis (NRXS), Envoy Medical (COCH), and DarioHealth (DRIO). These companies are all part of the "medical equipment" industry. Lifeward vs. Its Competitors NeuroOne Medical Technologies Precision Optics Titan Medical Vivos Therapeutics CollPlant Biotechnologies Retractable Technologies SeaStar Medical NeurAxis Envoy Medical DarioHealth NeuroOne Medical Technologies (NASDAQ:NMTC) and Lifeward (NASDAQ:LFWD) are both small-cap medical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, valuation, analyst recommendations, profitability, media sentiment and risk. Do insiders & institutionals have more ownership in NMTC or LFWD? 16.1% of NeuroOne Medical Technologies shares are held by institutional investors. Comparatively, 26.8% of Lifeward shares are held by institutional investors. 8.9% of NeuroOne Medical Technologies shares are held by company insiders. Comparatively, 2.7% of Lifeward shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is NMTC or LFWD more profitable? NeuroOne Medical Technologies has a net margin of -55.44% compared to Lifeward's net margin of -121.80%. Lifeward's return on equity of -137.91% beat NeuroOne Medical Technologies' return on equity.Company Net Margins Return on Equity Return on Assets NeuroOne Medical Technologies-55.44% -163.49% -78.67% Lifeward -121.80%-137.91%-90.28% Do analysts recommend NMTC or LFWD? NeuroOne Medical Technologies presently has a consensus target price of $1.45, indicating a potential upside of 98.39%. Lifeward has a consensus target price of $9.00, indicating a potential upside of 1,517.25%. Given Lifeward's higher possible upside, analysts clearly believe Lifeward is more favorable than NeuroOne Medical Technologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score NeuroOne Medical Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Lifeward 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has stronger earnings and valuation, NMTC or LFWD? NeuroOne Medical Technologies has higher earnings, but lower revenue than Lifeward. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Lifeward, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNeuroOne Medical Technologies$3.45M10.59-$12.32M-$0.15-4.87Lifeward$25.66M0.34-$28.94M-$3.12-0.18 Does the media refer more to NMTC or LFWD? In the previous week, Lifeward had 2 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 3 mentions for Lifeward and 1 mentions for NeuroOne Medical Technologies. Lifeward's average media sentiment score of 0.50 beat NeuroOne Medical Technologies' score of -1.00 indicating that Lifeward is being referred to more favorably in the news media. Company Overall Sentiment NeuroOne Medical Technologies Negative Lifeward Positive Which has more volatility and risk, NMTC or LFWD? NeuroOne Medical Technologies has a beta of 0.68, suggesting that its stock price is 32% less volatile than the S&P 500. Comparatively, Lifeward has a beta of 0.16, suggesting that its stock price is 84% less volatile than the S&P 500. SummaryLifeward beats NeuroOne Medical Technologies on 8 of the 15 factors compared between the two stocks. Get Lifeward News Delivered to You Automatically Sign up to receive the latest news and ratings for LFWD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LFWD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LFWD vs. The Competition Export to ExcelMetricLifewardINTERNET SOFTWARE IndustryComputer SectorNASDAQ ExchangeMarket Cap$8.96M$19.30B$30.33B$9.85BDividend YieldN/A3.44%3.16%4.51%P/E Ratio-0.1875.95436.8426.42Price / Sales0.3464.911,618.03119.09Price / CashN/A84.3936.1158.92Price / Book0.268.227.006.06Net Income-$28.94M$355.31M$807.65M$266.28M7 Day Performance-10.26%-2.30%-1.13%-0.76%1 Month Performance-20.50%0.20%2.35%3.83%1 Year Performance-82.33%65.40%24,024.61%24.39% Lifeward Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LFWDLifeward3.1895 of 5 stars$0.56-2.5%$9.00+1,517.3%-82.5%$8.96M$25.66M-0.1860Short Interest ↓NMTCNeuroOne Medical Technologies1.7118 of 5 stars$0.78-0.5%$1.45+86.6%-6.3%$38.85M$3.45M-5.1820Negative NewsShort Interest ↑POCIPrecision OpticsN/A$4.82-2.6%N/A-17.1%$36.97M$19.10M-5.4280Gap DownTMDIFTitan MedicalN/A$0.31-12.9%N/A+811.4%$35.66M$17.63M-0.2550VVOSVivos Therapeutics0.3029 of 5 stars$4.68+1.1%$4.82+2.9%+73.9%$34.90M$14.39M-2.77160CLGNCollPlant Biotechnologies2.9033 of 5 stars$2.66+1.1%$11.50+332.3%-49.4%$33.84M$510K-2.3570Short Interest ↓RVPRetractable Technologies2.9121 of 5 stars$0.83-2.1%N/A-14.7%$24.79M$38.16M-1.53240Positive NewsShort Interest ↓ICUSeaStar Medical1.1361 of 5 stars$0.88-1.0%N/A-82.3%$24.60M$140K-0.342Short Interest ↓NRXSNeurAxis3.5157 of 5 stars$2.49-2.0%$7.00+181.1%-18.8%$24.55M$3.22M-1.3519Short Interest ↓COCHEnvoy Medical2.5286 of 5 stars$1.13+0.9%$9.25+718.6%-60.1%$24.15M$220K-0.7834Analyst RevisionHigh Trading VolumeDRIODarioHealth1.9278 of 5 stars$0.53-4.0%$2.00+278.8%-43.3%$23.98M$27.04M-0.80200Stock Split Related Companies and Tools Related Companies NeuroOne Medical Technologies Competitors Precision Optics Competitors Titan Medical Competitors Vivos Therapeutics Competitors CollPlant Biotechnologies Competitors Retractable Technologies Competitors SeaStar Medical Competitors NeurAxis Competitors Envoy Medical Competitors DarioHealth Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LFWD) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredTrump’s national nightmare is hereThe headlines are shocking: Washington has taken a $10 billion stake in one of America’s biggest chipmakers — ...Porter & Company | SponsoredNewegg (NEGG) Earns BULLISH Rating – Up 934%The last time he shared a free AI stock pick like this, it soared 100%.Chaikin Analytics | SponsoredThe man running the U.S. dollar… is hoarding goldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lifeward Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lifeward With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.